Kidney transplant study probes immune cell secrets
NCT ID NCT01150487
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at immune cells in bone marrow and lymph nodes of kidney transplant donors and recipients. The goal was to create a detailed immune profile to better understand how the immune system works in transplantation. About 288 people took part, including both pre- and post-transplant patients and donors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
288 people
The number who actually took part.
- Started
-
Oct 2010
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 99 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria. * Pre or post renal transplant recipients. * Renal transplant donors. * Those who give voluntary written informed consent before performance of any study-related procedures, which are not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care. Exclusion criteria. * Any patient currently receiving systemic anticoagulation therapy with heparin or coumadin. * Patient has a platelet count of \<30 x 10(9)/L within 14 days before enrollment. * Patient has an absolute neutrophil count of ANC\<1.0 x 10(9)/L within 14 days before enrollment. * Patient has received other investigational drugs within14 days before enrollment. * Serious medical or psychiatric illness likely to interfere with participation in this clinical study. * Diagnosed or treated for malignancy within 5 years of enrollment, with the exception of complete resection of basal cell carcinoma or squamous cell carcinoma of the skin, an in situ malignancy, or low-risk prostate cancer after curative therapy. * Contraindication to kidney transplantation or donation-active infection, comorbid medical conditions, etc
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Kidney transplant recipients are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A Needle-Free future for kidney diagnosis?
- Can a vaccine protect the most vulnerable? a study probes immune response in transplant patients
- A little reward, a bigger impact: do gift cards boost kidney donor Follow-Up?
- Could a common diabetes drug protect transplanted kidneys?
- Can MRI replace needles for kidney transplant checkups?
- Could a diabetes drug duo protect transplanted kidneys?